1CYB image
Deposition Date 1992-02-24
Release Date 1994-01-31
Last Version Date 2024-06-05
Entry Detail
PDB ID:
1CYB
Title:
NMR STUDIES OF (U-13C)CYCLOSPORIN A BOUND TO CYCLOPHILIN: BOUND CONFORMATION AND PORTIONS OF CYCLOSPORIN INVOLVED IN BINDING
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Submitted:
20
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CYCLOSPORIN A
Chain IDs:A
Chain Length:11
Number of Molecules:1
Biological Source:TOLYPOCLADIUM INFLATUM
Ligand Molecules
Peptide-like Molecules
PRD_000142
Primary Citation
NMR Studies of [U-13C]Cyclosporin a Bound to Cyclophilin: Bound Conformation and Portions of Cyclosporin Involved in Binding.
Biochemistry 30 6574 ? (1991)
PMID: 2054356 DOI: 10.1021/BI00240A030

Abstact

Cyclosporin A (CsA), a potent immunosuppressant, is known to bind with high specificity to cyclophilin (CyP), a 17.7 kDa protein with peptidyl-prolyl isomerase activity. In order to investigate the three-dimensional structure of the CsA/CyP complex, we have applied a variety of multidimensional NMR methods in the study of uniformly 13C-labeled CsA bound to cyclophilin. The 1H and 13C NMR signals of cyclosporin A in the bound state have been assigned, and from a quantitative interpretation of the 3D NOE data, the bound conformation of CsA has been determined. Three-dimensional structures of CsA calculated from the NOE data by using a distance geometry/simulated appealing protocol were found to be very different from previously determined crystalline and solution conformations of uncomplexed CsA. In addition, from CsA/CyP NOEs, the portions of CsA that interact with cyclophilin were identified. For the most part, those CsA residues with NOEs to cyclophilin were the same residues important for cyclophilin binding and immunosuppressive activity as determined from structure/activity relationships. The structural information derived in this study together with the known structure/activity relationships for CsA analogues may prove useful in the design of improved immunosuppressants. Moreover, the approach that is described for obtaining the structural information is widely applicable to the study of small molecule/large molecule interactions.

Legend

Protein

Chemical

Disease